Journal
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
Volume 322, Issue 12, Pages 1209-1211Publisher
AMER MEDICAL ASSOC
DOI: 10.1001/jama.2019.10650
Keywords
-
Categories
Funding
- Conquer Cancer Foundation from the National Cancer Institute of the National Institutes of Health [5-T32-CA009615, K23-CA187185]
Ask authors/readers for more resources
This research letter discusses the association between label restrictions by the US Food and Drug Administration on first-line immunotherapy for advanced bladder cancer and subsequent changes in practice.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
